<Suppliers Price>

Small Cardioactive Peptide B (SCPB)

Names

[ CAS No. ]:
84746-43-0

[ Name ]:
Small Cardioactive Peptide B (SCPB)

[Synonym ]:
met-asn--leu-ala-phe-pro-arg-met (met-asn-tyr-leu-ala-phe-pro-arg-met amide)
small cardioactive peptide b
cardioactive peptide b (small)
h-met-asn-tyr-leu-ala-phe-pro-arg-met-nh2
met-asn-tyr-leu-ala-phe-pro-arg-met amide
met-asn-tyr-leu-ala-phe-pro-arg-met-nh2
mnylafprm-nh2
MET-ASN-TYR-LEU-ALA-PHE-PRO-ARG-MET-NH2
Small Cardioactive Peptide B (SCPB)

Biological Activity

[Description]:

Small Cardioactive Peptide B (SCPB), a neurally active peptide, stimulates adenylate cyclase activity in particulate fractions of both heart and gill tissues with EC50s of 0.1 and 1.0 μM, respectively.

[Related Catalog]:

Signaling Pathways >> GPCR/G Protein >> Adenylate Cyclase
Peptides
Research Areas >> Cardiovascular Disease
Research Areas >> Neurological Disease

[Target]

EC50: 0.1 μM (adenylate cyclase, in heart tissues), 1.0 μM (adenylate cyclase, in gill tissues)[1]


[In Vitro]

Small cardioactive peptide B (SCPB) is a neurally active peptide endogenous to Aplysia. Small cardioactive peptide B (SCPB) possesses cardioexcitatory effects in Aplysia and reported a threshold concentration of 0.01 nM for both native and synthetic Small cardioactive peptide B (SCPB) stimulated effects on the isolated heart. Effects of Small Cardioactive Peptide B (SCPB) on the physiology of the isolated heart and gill preparations from the mollusc Aplysia californica were examined. In addition, the effects of Small Cardioactive Peptide B (SCPB) and FMRFamide (Phe-Met-Arg-Phe-NH2) on adenylate cyclase activity are compared in particulate fractions of heart and gill tissues, respectively. Small Cardioactive Peptide B (SCPB) is found to exert dose-dependent, reversible changes in cardiac activity when perfused through the isolated heart. The EC50 values effecting changes in heart rate and force of contraction are 0.03 and 0.3 nM, respectively; minimum concentrations find to effect changes in heart rate and force of contraction are normally 0.001 and 1 pM, respectively. When perfused through the isolated gill, Small Cardioactive Peptide B (SCPB) is found to suppress the gill withdrawal response amplitude with a threshold concentration of 0.01 pM and an EC50 value of 0.03 nM. Suppression of the gill withdrawal response amplitude by Small Cardioactive Peptide B (SCPB)is found to be dose dependent and reversible up to a concentration of 1nM. At higher concentrations, the suppression tended to persist irreversibly. Small Cardioactive Peptide B (SCPB) stimulates adenylate cyclase activity in particulate fractions of both heart and gill tissues with an EC50 of 0.1 and 1.0μM, respectively[1].

[References]

[1]. Cawthorpe DR, et al. The effects of small cardioactive peptide B on the isolated heart and gill of Aplysia californica. Can J Physiol Pharmacol. 1985 Aug;63(8):918-24.


[Related Small Molecules]

Forskolin | SQ22536 | α-MSH trifluoroacetate salt | ST 034307 | CB-7921220

Chemical & Physical Properties

[ Density]:
1.41 g/cm3

[ Molecular Formula ]:
C52H80N14O11S2

[ Molecular Weight ]:
1141.41000

[ Exact Mass ]:
1140.56000

[ PSA ]:
468.94000

[ LogP ]:
4.05150

[ Index of Refraction ]:
1.656

[ Storage condition ]:
2-8℃

MSDS

Safety Information

[ WGK Germany ]:
3


Related Compounds